Westerkirk Capital Inc. Sells 5,900 Shares of Procter & Gamble Company (The) $PG

Westerkirk Capital Inc. lowered its stake in Procter & Gamble Company (The) (NYSE:PG) by 19.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 24,200 shares of the company’s stock after selling 5,900 shares during the quarter. Westerkirk Capital Inc.’s holdings in Procter & Gamble were worth $3,718,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Czech National Bank boosted its position in Procter & Gamble by 3.8% in the third quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after buying an additional 21,825 shares in the last quarter. Vega Investment Solutions lifted its stake in shares of Procter & Gamble by 1.3% in the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock valued at $101,710,000 after acquiring an additional 8,500 shares during the last quarter. Jump Financial LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at $7,891,000. SVB Wealth LLC bought a new stake in Procter & Gamble during the 2nd quarter worth $12,725,000. Finally, Vanguard Group Inc. grew its position in Procter & Gamble by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock worth $36,050,992,000 after acquiring an additional 1,419,322 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG opened at $160.77 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $179.99. The company has a 50 day simple moving average of $149.02 and a two-hundred day simple moving average of $150.70. The company has a market capitalization of $373.62 billion, a PE ratio of 23.82, a P/E/G ratio of 5.34 and a beta of 0.38.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the prior year, the firm posted $1.88 EPS. The company’s quarterly revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, January 23rd. Procter & Gamble’s payout ratio is currently 62.67%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on PG shares. Barclays set a $155.00 target price on Procter & Gamble in a research report on Friday, January 16th. Deutsche Bank Aktiengesellschaft lowered their price objective on Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Finally, BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research note on Friday, January 16th. Fourteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $168.33.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares in the company, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,827 shares of Procter & Gamble stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the completion of the sale, the insider owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This represents a 50.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 341,260 shares of company stock worth $54,256,985 over the last quarter. 0.20% of the stock is owned by company insiders.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.